Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Small Cell Lung Cancer Limited Stage × Chemoradiotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Rectal Neoplasms 2 Mouth Neoplasms 2 Uterine Cervical Dysplasia 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Cancer Limited Stage 1 Pancreatic Neoplasms 1 Nasopharyngeal Carcinoma 1 Head and Neck Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Solid Tumors 1

Interventions

anlotinib 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04882033 2021-05-11

Concurrent Chemoradiotherapy Combination With Anlotinib for Limited-stage Small Cell Lung Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 1 Unknown

Small Cell Lung Cancer Limited Stage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡